In 2012 some 207 million people – more than 80 percent of them from Africa – contracted malaria. Around 627,000 of these people, including a large number of children under 5, subsequently died of the disease (Source “World Malaria Report”, WHO 2013). In several African countries, such as Ethiopia, Uganda, Zambia and Malawi, Bayer for many years has participated actively in the fight against malaria, which is transmitted by the Anopheles mosquito. Two projects give special grounds for hope. A bed net sets new standards in prophylaxis and in active substance research the foundations have been laid for a breakthrough in the fight against the insects which transmit malaria.
For Ildem Bozkurt, Project Manager in the field of vector control at Environmental Science, the LifeNet™ represents a logical development: “Bayer has played a key role in the development of insecticide-treated nets. Today, our insecticides are used in a broad range of nets. The LifeNet™ is the logical progression.” The net is currently being tested by the WHO in Africa and India and preparations for market launch are also under way. Bayer is also working closely on another ambitious project with the Innovative Vector Control Consortium (IVCC), an affiliation of leading institutions in the field of product development and information systems for improved vector control.